Literature DB >> 32966479

Identification of polyphenol from Ziziphi spinosae semen against human colon cancer cells and colitis-associated colorectal cancer in mice.

Shuhua Shan1, Yue Xie1, Chengying Zhang2, Bin Jia3, Hanqing Li2, Zhuoyu Li4.   

Abstract

Homology of medicine and food-zizyphi spinosi semen (ZSS) exhibits abundant pharmacological activities, such as sedation, hypnosis and anti-depression. In the present study, the water soluble polyphenols extracted from ZSS via the acid digestion method were named ZSSP, and exhibited significant anti-colorectal cancer (CRC) activity, characterized by restraining cell proliferation, promoting cell apoptosis and increasing chemo-sensitivity of CRC cells. The potential of ZSSP in vivo was further evaluated in an AOM/DSS-induced colitis-associated carcinogenesis (CAC) mouse model. Intriguingly, ZSSP diminished the number and volume of CAC polyps in mice in a dose-dependent manner, and effectively limited the damage of mice organs induced by AOM/DSS. The immunohistochemistry result showed that the elevated CRC early markers in CAC mice, such as COX-II, EMR1, and Ki67, were potently prevented by the ZSSP treatment. Further, the component in ZSSP with the anti-CRC activity was identified as spinosin by the macroporous resin of SP207 and RP-HPLC-MS/MS. Interestingly, during the extraction process, sodium ions were introduced forming spinosin·Na+, which had better water solubility and more remarkable anti-CRC activity than the spinosin. This study provides a new pharmacological property of spinosin derived from ZSS, inhibiting the growth of human CRC cells and colitis-associated CRC in mice, which indicates its potential use as a natural agent against CRC.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32966479     DOI: 10.1039/d0fo01375g

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   6.317


  1 in total

Review 1.  The pharmacology, pharmacokinetics, and toxicity of spinosin: A mini review.

Authors:  Xiaolan Kuang; Ganshu She; Ting Ma; Wanna Cai; Jingjing Zhao; Bo Liu; Fangfang Xu
Journal:  Front Pharmacol       Date:  2022-09-12       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.